Comparative characterisation of the discriminative stimulus properties of clozapine and other antipsychotics in rats

Psychopharmacology

Volumn 135, Issue 4, 1998, Pages 392-400

  Goudie, Andrew ^a   Taylor, Anita ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Amphetamine; Clozapine; Drug discrimination; Haloperidol; JL13; Loxapine; Neuroleptic; Olanzapine; Pentylenetetrazole; Rat; Risperidone; Ser tindole; Seroquel

Indexed keywords

AMISULPRIDE; AMPHETAMINE; CHLORDIAZEPOXIDE; CLOZAPINE; HALOPERIDOL; JL 13; LOXAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PENTETRAZOLE; QUETIAPINE; RISPERIDONE; SERTINDOLE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIPSYCHOTIC AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS; CLOZAPINE; CONDITIONING, OPERANT; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENERALIZATION, STIMULUS; RATS; RATS, WISTAR;

EID: 0031747077     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050527     Document Type: Article

References (50)

1. Andrews JS, Turski L, Stephens DN (1989) Does the pentylenetetrazol (PTZ) cue reflect PTZ-induced kindling or PTZ-induced anxiogenesis? Drug Dev Res 16:247-256
2. Arnt J (1992) Sertindole and several antipsychotic drugs differentially inhibit the discriminative stimulus effects of amphetamine, LSD and St 587 in rats. Behav Pharmacol 3: 11-18
3. Arnt J (1996) Inhibitory effects on the discriminative stimulus properties of d-amphetamine by classical and newer antipsychotics do not correlate with antipsychotic activity. Relation to effects on reward? Psychopharmacology 124: 114-125
4. Ashby CR, Wang RY (1997) Pharmacological actions of the atypical antipsychotic clozapine: a review. Synapse 24: 349-394
5. Browne RG, Koe BK (1982) Clozapine and agents with similar behavioral and biochemical properties. In: Colpaert FC, Slangen JL (eds) Drug discrimination: applications in CNS pharmacology. Elsevier, Amsterdam, pp 241-254
6. Bruhwyler J, Liegeois J-F, Chleide E. Register F, Damas J, Delarge J, Mercier M (1992) Comparative study of typical neuroleptics, clozapine and newly synthesised clozapine-analogues: correlations between neurochemistry and behaviour, Behav Pharmacol 3: 567-579
7. Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, Seeman P, Wong DT (1996) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14:87-96
8. Carey G, Bergman J (1997) Discriminative stimulus effects of clozapine in squirrel monkeys: comparison with conventional and novel atypical antipsychotic drugs. Psychopharmacology (in press)
9. Colpaert FC, Niemegeers CJE, Janssen PAJ (1976) Theoretical and methodological considerations on drug discrimination learning. Psychopharmacologia 46: 169 177
10. 2-like" agonist RU 24213. Psychopharmacology 124:40 49
11. Emmett-Oglesby MW, Spencer DG, Elmesallamy F, Lal H (1983) The pentylenetetrazol model of anxiety detects withdrawal from diazepam in rats. Life Sci 33: 161-168
12. Extance K, Goudie AJ (1981) Inter-animal olfactory cues in operant drug discrimination procedures in rats. Psychopharmacology 73: 363-371
13. Franklin SR, Tang AH (1994) Discriminative stimulus effects of clozapine in rats. Behav Pharmacol 5 [Suppl]: 113
14. Gerlach J, Peacock L (1995) New antipsychotics: the present status. Int Clin Psychopharmacol 10: 39-48
15. Goas JA, Boston JE (1978) Discriminative stimulus properties of clozapine and chlorpromazine. Pharmacol Biochem Behav 8: 235-241
16. Goldstein JM (1995) Preclinical tests that predict clozapine-like atypical antipsychotic actions. In: Brunello N, Racagni G, Langer SZ (eds) Critical issues in the treatment of schizophrenia. International Academy of Biomedical Research. Karger, Basel, pp 95-101
17. Goudie AJ, Leathley MJ (1993) Drug discrimination assays. In: Sahgal A (ed) Behavioural neuroscience. Oxford University Press, pp 145-167
18. Goudie AJ, Dubicki W, Leathley M (1988) Paroxetine, a selective 5-hydroxytryptamine uptake inhibitor with antidepressant properties, lacks amphetamine-like stimulus properties in an operant drug discrimination bioassay in rodents. J Pharm Pharmacol 40: 192-196
19. Goudie AJ, Leahy E, Taylor A (1996) Tolerance to actions of clozapine on operant responding is not associated with dependence (abstract). J Psychopharmacol 8
20. Goudie AJ, Taylor A, Smith J (1997) Clozapine drug discrimination in rats: effects of atypical neuroleptics. Br J Pharmacol 120 [Suppl]: 242
21. 3 receptor. Biochem Biophysic Res Commun 225:957-960
22. 2 receptors. J Pharmacol Exp Ther 263:276 284
23. Kane J, Honigfeld G, Singer J, Meltzer H (1988) Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45: 789-796
24. Kane JM (1996) Drug therapy: schizophrenia. N Engl J Med 334:34-41
25. Kinon BJ, Lieberman JA (1996) Mechanisms of action of atypical antipsychotic drugs. Psychopharmacology 124:2 34
26. Kurz M, Hummer M, Oberbauer H, Fleischhacker WW (1995) Extrapyramidal side effects of clozapine and haloperidol. Psychopharmacology 118:52-56
27. 2 receptors. Psychopharmacology 112:S40-S54
28. Leysen JE, Janssen PMF, Megens AAHP, Schotte A (1994) Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism. Receptor occupancy profile, and pharmacologic activity. 9th World Congress of Psychiatry: risperidone: new horizons for the schizophrenic patient (1993, Rio de Janeiro, Brazil). J Clin Psychiatry 55: 5 12
29. Liegeois J-F, Register FA, Bruhwyler J, Damas J, Nguygen TP. Inarejos M-O, Chielde EMG, Mercier MGA, Delarge JE (1994) Pyridobenzoxapine and pyridobenzothiazepine derivatives as potential central nervous system agents: synthesis and neurochemical study. J Med Chem 37: 519 525
30. Meltzer HY (1996) Pre-clinical pharmacology of atypical antipsychotic drugs: a selective review. Br J Psychiatry 168:23-31
31. Meltzer HY, Lee MA, Ranjan R (1994) Recent advances in the pharmacotherapy of schizophrenia. Acta Psychiatr Scand Suppl 90:95-101
32. Migler BM, Warawa EJ, Malick JB (1993) Seroquel: behavioral effects in conventional and novel tests for atypical antipsychotic drug. Psychopharmacology 112:299-307
33. Moore NA, Tye NC, Axton MS, Risius FC (1992) The behavioural pharmacology of olanzapine, a novel "atypical" antipsychotic agent. J Pharmacol Exp Ther 262:545-551
34. Moore NA, Rees G, Sanger G, Tye NC (1994) Effects of olanzapine and other antipsychotic agents on responding maintained by a conflict schedule. Behav Pharmacol 5: 196 202
35. Moore NC, LeWitt PA, Gershon S (1992) Reduction of dyskinesias and psychiatric disability with clozapine over different time courses. J Psychopharmacol 6: 514-518
36. Moran PM, Fischer TR, Hitchcock JM. Moser PC (1996) Effects of clozapine on latent inhibition in the rat. Behav Pharmacol 7:42-48
37. Nielsen EB (1988) Cholinergic mediation of the discriminative stimulus properties of clozapine. Psychopharmacology 94: 115-118
38. Ortmann R, Meisburger JG, Bischoffs, Hauser K (1986) The clozapine cue in rats as tool for the characterization of neuroleptics, Psychopharmacology 89: S47
39. Pacia SV, Devinsky O (1994) Clozapine-related seizures: experience with 5.629 patients. Neurology 44: 2247 2249
40. Perrault G, Depoorterre R, Morel E, Sanger DJ, Seatton B (1997) Psychopharmacological profile of amisulpiride: an antipsychotic with presynaptic D-2/D-3 dopamine receptor antagonist activity and limbic selectivity. J Pharmacol Exp Ther 280: 73 82
41. Porter JH, Strong SE (1996) Discriminative stimulus control with olanzapine: generalization to the atypical antipsychotic clozapine. Psychophamacology 128: 216 219
42. Prinssen EPM, Ellenbrook BA, Cools AR (1994) Combined antagonism of adrenoceptors and dopamine and 5-HT receptors underlies the atypical profile of clozapine. Eur J Pharmacol 262: 167 170
43. Sanchez C, Arnt J, Dragsted N, Hyttel J, Lembol HL, Meier E, Perregaard J, Skarsfeldt T (1991) Neurochemical and in vivo pharmacological profile of sertindole, a limbic-selective neuroleptic compound. Drug Dev Res 22: 239 250
44. Sanger DJ, Perrault G (1995) Effects of typical and atypical antipsychotic drugs on response decrement patterns in rats. J Pharmacol Exp Ther 272: 708 713
45. 3 receptor antagonist with both presynaptic and limbic selectivity. J Pharmacol Exp Ther 280:83 97
46. Swerdlow NR, Zisook D, Taaid N (1994) Seroquel (ICI 204,636) restores prepulse inhibition of acoustic startle in apomorphine-treated rats: similarities to clozapine. Psychopharmacology 114:675 678
47. Tang AM, Franklin SR, Himes CS, Smith MW, Tenbrink RE (1997) PNU-96415E, a potential antipsychotic agent with clozapine-like pharmacological properties. J Pharmacol Exp Ther 281:440 447
48. Taylor A, Goudie AJ, Smith J (1997) Clozapine drug discrimination in rats: a pharmacologically specific stimulus. Br J Pharmacol 120 [Suppl]: 241
49. Villaneuva HF, Arezo S, Rosecrans JA (1992) Nicotine does not interact with the discriminative stimulus properties of clozapine in rats. Drug Dev Res 26: 195 202
50. Wiley JL, Porter JH (1992) Serotonergic drugs do not substitute for clozapine in clozapine-trained rats in a two-lever drug discrimination procedure. Pharmacol Biochem Behav 43: 961 965